HOW did GLP-1RAs bring about a paradigm shift in the guidelines of managing T2DM: A path to gluco-cardio Centricity.
GLP-1RAs 如何在管理T2DM的指引中帶來範式轉變:通往葡萄糖心臟中心的道路。
Indian Heart J 2023-03-08
Intensified glycemic control by HbA1c for patients with coronary heart disease and Type 2 diabetes: a review of findings and conclusions.
冠心病和第2型糖尿病患者的HbA1c強化血糖控制:研究結果和結論回顧。
Cardiovasc Diabetol 2023-11-22
Cardiovascular prevention with glucose-lowering drugs in type 2 diabetes: An evidence-based approach to the categories of primary and secondary prevention.
第二型糖尿病中以降糖藥物進行心血管預防:基於證據的初級與次級預防分類方法。
Diabetes Obes Metab 2023-11-21
Trends in prognosis and use of SGLT2i and GLP-1 RA in patients with diabetes and coronary artery disease.
糖尿病與冠狀動脈疾病患者中 SGLT2i 和 GLP-1 RA 的預後趨勢及使用情況。
Cardiovasc Diabetol 2024-08-07
GLP-1 RAs and SGLT2-Is to Lower Glucose and Reduce the Risk of Cardiovascular and Diabetic Kidney Disease.
GLP-1 受體激動劑和 SGLT2 抑制劑降低血糖並減少心血管疾病及糖尿病腎病的風險。
J Am Board Fam Med 2024-08-14